HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lauder Q4 and full year

This article was originally published in The Rose Sheet

Executive Summary

The Estee Lauder Companies booked net sales of $7.04 bil. in FY 2007, a 9% increase over 2006, the company announces Aug. 16. Skin-care sales were up 8.3% on a reported basis to $2.6 bil., driven by solid sales in Asia and Europe, launches from Estee Lauder and Clinique brands and increasing sales of La Mer and Resilience Lift Extreme Ultra Firming products by Lauder and the 3-Step Skin Care System by Clinique. Fragrance sales rose 7.9% to $1.32 bil. on strong sales in Europe, the Middle East and Africa and the performance of DKNY Red Delicious and Pure White Linen by Estee Lauder. Lauder sold $2.71 bil. worth of makeup, an increase of 8.3% over the prior-year period; firm cites the success of its makeup artist brands. Hair-care revenue shot up 18.3% to $377 mil., with significant contributions from Aveda and Bumble and Bumble sales. Skin care, makeup and fragrance were adversely affected by department store closings, but this was offset by gains in Internet distribution and growth in company's makeup brands and hair care. For the fourth quarter, Lauder recorded net sales of $1.76 bil, up 7% excluding the impact of foreign currency translation. Sales rose in all regions and product categories, the firm says. Lauder projects that net sales in FY 2008 will increase 7% to 9%....

You may also be interested in...

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts